Telemedicine for Patients With Chronic Respiratory Insufficiency

Sponsor
Michele Vitacca (Other)
Overall Status
Completed
CT.gov ID
NCT00563745
Collaborator
Fondazione Salvatore Maugeri (Other)
240
1
2
36
6.7

Study Details

Study Description

Brief Summary

In unstable patients needing oxygen and/or home mechanical ventilation, a nurse-centred TM programme (supported by continuous availability of a call centre and a pulsed oxygen system) is cost/effective saving health care resources.

Condition or Disease Intervention/Treatment Phase
  • Device: telemedicine program
N/A

Detailed Description

Background: Integrated care and strict follow up have been recommended for frail patients with chronic respiratory failure (CRF) discharged at home.

Objectives: To evaluate impact and costs on health care resources of a telemedicine programme (TM) for severe patients discharged at home with oxygen and/or home mechanical ventilation (HMV) with a high risk of hospital readmission.

Design: Prospective randomised controlled trial. Setting: Respiratory Rehabilitation Unit S. Maugeri Foundation between May 2004 and March 2007.

Participants: 240 CRF patients will be randomised into an intervention group (TM) and a control Group, which received current usual care (educational plan, 3 months outpatient visits).

Interventions: one year TM with continuous (h 24) on call accessibility to a nurse and/or a pulmonologist, a web-based call centre and a pulse oxymetry tracing.

Main outcome measures: survival, admissions to emergency room (ER), hospitalisations, urgent general practitioner (GP) calls, home relapses; probability to remain free from the above events will be also compared among groups. TM and health Care System costs as customer satisfaction will be also collected.

Study Design

Study Type:
Interventional
Actual Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Randomised Trial on Telemedicine to Save Health Care Requests for Patients With Severe Chronic Respiratory Failure.
Study Start Date :
Apr 1, 2004
Actual Primary Completion Date :
Apr 1, 2005
Actual Study Completion Date :
Apr 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telemedicine

Patients were submitted to a Telemedicine program for 1 year

Device: telemedicine program
One year TM with continuous (h 24) on call accessibility to a nurse and/or a pulmonologist, a web-based call centre and a pulse oxymetry tracing will be provided.
Other Names:
  • home care
  • No Intervention: Control group

    Patients were submitted to usual care (i.e: educational plan and outpatient visits every 3 months)

    Outcome Measures

    Primary Outcome Measures

    1. To evaluate impact and costs on health care resources of a telemedicine programme (TM) for severe patients discharged with oxygen and/or home mechanical ventilation (HMV) with high risk of hospital readmission. [3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • CRF patients discharged from Respiratory Unit with home MV
    Exclusion Criteria:
    • Severe co morbid conditions, i.e. lung cancer or other advanced malignancies, and extremely severe neurological disorders (with impaired cognitive status, ability to understand medical instructions, dementia or severe psychiatric illness)

    • Logistical limitations due to extremely poor social conditions, such as illiteracy or no telephone access at home

    • Being admitted to a nursing home

    • Lack of caregiver when ventilated invasively (i.e. tracheal cannula with sounds uncertain) to allow a contact between care team and family

    • Refusal to give informed consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Telemedicine Service, Fondazione S. Maugeri, IRCCS Lumezzane Brescia Italy 25065

    Sponsors and Collaborators

    • Michele Vitacca
    • Fondazione Salvatore Maugeri

    Investigators

    • Principal Investigator: Michele Vitacca, MD, Fondazione S. Maugeri IRCCS

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Michele Vitacca, Fondazione Salvatore Maugeri, Fondazione Salvatore Maugeri
    ClinicalTrials.gov Identifier:
    NCT00563745
    Other Study ID Numbers:
    • N°158
    First Posted:
    Nov 26, 2007
    Last Update Posted:
    Mar 6, 2015
    Last Verified:
    Mar 1, 2015

    Study Results

    No Results Posted as of Mar 6, 2015